基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用

崔园园; 周永峰; 马艳芹; 张蓉蓉; 董旖; 房吉祥; 王国强; 张萍

doi:10.14009/j.issn.1672-2124.2020.06.001

您当前的位置：

首页 >

文章列表页 >

基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用

热点关注 | 更新时间：2022-10-08

- 基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用
- Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine
- 中国医院用药评价与分析 2020年20卷第6期页码：641-644
- 作者机构：
  
  中国人民解放军总医院第五医学中心中药房
- 作者简介：
- 基金信息：
  
  国家重点研发计划（No.2018YFC1706502）;首都卫生发展科研专项（No．首发2018-2-5031）;军民标准通用化工程项目（No.BWS17B038）
- DOI：10.14009/j.issn.1672-2124.2020.06.001
  中图分类号： R259
- 纸质出版日期：2020，
扫描看全文
[1]崔园园,周永峰,马艳芹,张蓉蓉,董旖,房吉祥,王国强,张萍.基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用[J].中国医院用药评价与分析,2020,20(06):641-644.

CUI Yuanyuan, ZHOU Yongfeng, MA Yanqin, et al. Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine[J]. 2020,20(6):641-644.
[1]崔园园,周永峰,马艳芹,张蓉蓉,董旖,房吉祥,王国强,张萍.基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用[J].中国医院用药评价与分析,2020,20(06):641-644. DOI： 10.14009/j.issn.1672-2124.2020.06.001.

CUI Yuanyuan, ZHOU Yongfeng, MA Yanqin, et al. Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine[J]. 2020,20(6):641-644. DOI： 10.14009/j.issn.1672-2124.2020.06.001.

摘要

作为一种急性病毒性传染病

新型冠状病毒肺炎（COVID-19）已被纳入《中华人民共和国传染病防治法》规定的乙类传染病。抗病毒药是治疗病毒性传染病的重要手段

针对COVID-19

目前已有148项相关药物注册临床试验

但至今尚无特效药。鉴于近年来从中医"毒邪"理论辨治难治性、病毒性疾病的效果凸显且应用广泛

本文试从中医"毒邪"理论探讨COVID-19的发病机制

整合分析现有的治疗COVID-19中药的筛选和临床应用规律

以期发现具有潜在价值的基础方药

为治疗COVID-19中药的临床应用提供参考。

Abstract

As a kind of acute viral infectious disease

COVID-19 has been included in the category B infectious diseases under the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases. The antiviral drugs are an important tool in the treatment of viral infectious diseases. For COVID-19

148 kinds of elated drugs have been registered in clinical trials

but there is no effective drug yet. In view of the significant and widespread application of Poison Theory of traditional Chinese medicine in the treatment of refractory and viral diseases in recent years

this paper attempts to explore the pathogenesis of COVID-19 from Poison Theory of traditional Chinese medicine

and integrates and analyzes the existing screening and clinical application patterns of traditional Chinese medicine for the treatment of COVID-19

with a view to discovering potentially valuable basic prescription drugs for the clinical application of traditional Chinese medicine

and provide reference for the treatment of COVID-19.

关键词

新型冠状病毒肺炎中医药“毒邪”理论

Keywords

COVID-19Traditional Chinese medicinePoison Theory

references

查看原文

浏览量

176

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

基于数据挖掘的中药治疗肝癌经导管动脉化疗栓塞术后用药规律探析

基于数据挖掘和网络药理学探讨中医药治疗骨质疏松症的用药规律及机制

阿比多尔抗病毒研究进展

益气活血法联合西医常规治疗用于气虚血瘀型急性缺血性脑卒中患者的临床疗效及安全性研究